CHU La Timone Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2018
NCT03585465
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

APHM - Hôpital Timone Enfants | APHM - La Timone | CHU La Timone